Compare CET & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CET | ATAI |
|---|---|---|
| Founded | 1929 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 2021 |
| Metric | CET | ATAI |
|---|---|---|
| Price | $50.85 | $4.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | 38.3K | ★ 3.2M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.40 | N/A |
| Revenue | ★ $27,062,484.00 | $3,018,000.00 |
| Revenue This Year | N/A | $943.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.85 | ★ N/A |
| Revenue Growth | 15.78 | ★ 811.78 |
| 52 Week Low | $40.24 | $1.15 |
| 52 Week High | $52.44 | $6.75 |
| Indicator | CET | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 46.02 |
| Support Level | $50.60 | $3.90 |
| Resistance Level | $51.31 | $4.72 |
| Average True Range (ATR) | 0.66 | 0.24 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 58.90 | 23.21 |
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.